Israeli Cannabis Exports on Hold as PM Awaits Further Research

3

Israeli Prime Minister Benjamin Netanyahu rejected necessary permits to export medical cannabis from Israel to Germany and other EU-countries. Netanyahu is awaiting results of new clinical trials from the health ministry as well as a National Economic Council study before allowing Israeli growers to export medical cannabis produced under the health ministry’s supervision.

Netanyahu announced his decision on Sunday following a meeting with Finance Minister Moshe Kahlon and Security Secretary Gilad Erdan. In August 2017, an inter-ministerial committee recommended and approved the export of medical cannabis. According to  Security Minister Erdan, he found indicators that cannabis grown for medicinal purposes was being misused for recreational purposes.

The findings prompted the Security Secretary to reject export plans for the time being.

Another reason for the unexpected move could be a change in United States’ position on the matter. U.S. President Donald Trump called the Israeli Prime Minister on Sunday before the meeting with Kahlon and Erdan, as reported by the Jerusalem Post. On the call, Trump expressed his displeasure with the medical cannabis export plan, proposed to be worth between $1-4 billion.

According to Netanyahu’s decision, medical cannabis from Israel will not be offered in German pharmacies for the foreseeable future. Patients, doctors, and policymakers alike had hoped to bridge the current bottlenecks in the supply chain with medicine from Israel. In December, the German federal government stated the import of cannabis cultivated from abroad is an option which is already being discussed in Israel on an inter-ministerial level. Now it seems the market will be split among a handful of Canadian producers and one Dutch company before Germany starts domestic production in 2020.

 

About Author

Michael Knodt is an expert on cannabis politics and cannabis culture across Europe. Born in North Germany, Michael has been living in Berlin since 1990. He initially studied history and journalism before receiving his certification as a carpenter. Since then, Michael has made regular visits to countries where cannabis is cultivated, such as Jamaica and Morocco. He has worked as a freelancer for Weedmaps, Vice Magazine Germany, Sensi Seeds and numerous German-language cannabis magazines since 2004. From 2005 to 2013, Michael was the Editor-in-Chief of Germanys biggest cannabis periodical. He also is the face and presenter of the most popular program on cannabis prohibition and just launched a new channel called "DerMicha." Aside from his journalistic work, Michael is a cannabis patient, activist, sought-after speaker on conferences and congresses, and a father of two.

3 Comments

  1. trump appointed sessions.. unelected sessions controls scheduling.. everything they do includes consideration of – ‘what message does it send’.. trump expressing ‘displeasure’ carries far more than some real estate manipulator cum politician getting his balls in a knot…

    trump and his crew control many things, potential things, including for eg, who gets missiles and other weapons.. who gets us military support, and so on..

    mr trump may well be a quiet and mild mannered trustworthy gentleman, however theres no telling what potentials his ‘displeasure’ might have,, for anyone or anything in his sights..

Leave A Reply